Post TAVI pacemaker implantation does not increase mortality

Original Title: Impact of New-Onset Left Bundle Branch Block and Periprocedural Permanent Pacemaker Implantation on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement. A Systematic Review and Meta-Analysis.
Reference: Ander Regueiro et al. Circ Cardiovasc Interv. 2016 May;9(5).

 

Available data on the clinical impact of the new-onset left bundle branch block (LBBB) and the need of permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation (TAVI) remain controversial.

The aim of this meta-analyzis was, on one hand, to assess the impact of the new-onset LBBB and PPI on all-cause mortality at one year and, on the other hand, to determine the new-onset LBBB predictive value on the need of PPI.

In all, this meta-analyzis included 17 studies with 11788 patients with data on the impact of the new-onset LBBB and the need of PPI. The new-onset LBBB post TAVI was associated with a greater need of PPI (RR 2.18; CI 95%, 1.28 to 3.70) and a higher risk of cardiac death (RR 1.39; CI 95% 1.04 to 1.86) as well as a tendency to increase all-cause mortality (RR 1.21; CI 95% 0.98 to 1.50).

The need of PPI post TAVI was not associated to an increase in all-cause mortality at one year (RR 1.03; CI 95% 0.9 to 1.18). In fact, it showed a tendency to have a protective effect against cardiac death (RR 0.78; CI 95% 0.60–1.03).

Conclusion
The new-onset left bundle branch block post TAVI is a risk marker of cardiac death and need of PPI at one year follow up. The need of PPI immediately post implantation, was not associated with an increase in mortality.

More articles by this author

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

ACC 2026 | Extended follow-up of the TRI-FR study: Edge-to-edge percutaneous repair in isolated severe tricuspid regurgitation

Severe tricuspid regurgitation (TR) is associated with chronic systemic venous congestion, recurrent hospitalizations for heart failure (HF), and a significant deterioration in quality of...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...